Fibrosis in hepatitis C patients predicts complications after elective total joint arthroplasty

J Arthroplasty. 2014 Jan;29(1):7-10. doi: 10.1016/j.arth.2013.03.023. Epub 2013 May 4.

Abstract

Effects of Hepatitis C on total hip (THA) and total knee arthroplasty (TKA) outcomes are poorly understood. Seventy-two hepatitis C patients underwent 77 primary THA or TKA and were retrospectively identified, stratified by fibrosis and thrombocytopenia and compared to matched controls. Overall, Hepatitis C and control patients had similar outcomes. After TKA, fibrotic hepatitis C patients demonstrated a greater average hemoglobin drop than non-fibrotic hepatitis C patients (4.9 versus 3.8, P=0.023), greater deep infection rate (21% versus 0%, P=0.047), and rate of cellulitis (21% versus 0%, P=0.047). Thrombocytopenia showed a trend toward greater infections. Prior to fibrosis, Hepatitis C patients appear to be at no increased risk of complication after joint arthroplasty. Evaluation of fibrosis may predict poor outcome in Hepatitis C patients.

Keywords: Outcomes; complications; fibrosis; hepatitis C; total joint arthroplasty.

MeSH terms

  • Aged
  • Arthroplasty, Replacement, Hip / adverse effects*
  • Arthroplasty, Replacement, Knee / adverse effects*
  • Female
  • Fibrosis / etiology
  • Hepatitis C / complications*
  • Humans
  • Joint Diseases / complications
  • Joint Diseases / surgery*
  • Liver Cirrhosis
  • Male
  • Middle Aged
  • Retrospective Studies
  • Thrombocytopenia / etiology